Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Mar 25, 2025; 14(1): 100338
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.100338
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.100338
Serological surveillance for SARS-CoV-2 antibodies among students, faculty and staff within a large university system during the pandemic
Marcos G Pinheiro, Gabriela G O Alves, Maria Eduarda R Conde, Sofia L Costa, Regina C S Sant’Anna, Isa M F Antunes, Julia C Scaffo, Felipe R Pinheiro, Lialyz S Andre, Laboratory of Molecular Epidemiology and Biotechnology, Rodolpho Albino University Laboratory, Fluminense Federal University, Niterói 24241000, Rio de Janeiro, Brazil
Marcos G Pinheiro, Mônica C Carneiro, Fabio S Ronzei, Estácio de Sá University, Nova Friburgo 28611135, Rio de Janeiro, Brazil
Marcos G Pinheiro, Felipe R Pinheiro, Lialyz S Andre, Fabio Aguiar-Alves, Pathology Program, Medicine school, Fluminense Federal University, Niterói 24070090, Rio de Janeiro, Brazil
Gabriela G O Alves, Fabio Aguiar-Alves, Department of Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL 33401, United States
Helvecio C Povoa, Fabíola Giordani, Health Institute of Nova Friburgo, Fluminense Federal University, Nova Friburgo 28613001, Rio de Janeiro, Brazil
Valéria T Baltar, Eduarda S Hemerly, Gisele C Alexandre, Jackeline Christiane P Lobato, Department of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói 24033900, Rio de Janeiro, Brazil
Karla C de Paula, Institute of Physical Education, Fluminense Federal University, Niterói 24020005, Rio de Janeiro, Brazil
Márcio Watanabe, Department of Statistics, Fluminense Federal University, Niterói 24210200, Rio de Janeiro, Brazil
Antonio Claudio L da Nóbrega, Department of Physiology and Pharmacology, Fluminense Federal University, Niterói 24210130, Rio de Janeiro, Brazil
Co-corresponding authors: Jackeline Christiane P Lobato and Fabio Aguiar-Alves.
Author contributions: Pinheiro MG, Nóbrega ACLD, Lobato JCP, and Aguiar-Alves F conceptualized and supervised the study; Nóbrega ACLD, Lobato JCP, and Aguiar-Alves F were involved in funding acquisition, resources and project administration; Baltar VT and Giordani F were involved in statistical analysis; Pinheiro MG, Alves GGO, Povoa HC, Hemerly ES, Alexandre GC, de Paula KC, Watanabe M, Lobato JCP, and Aguiar-Alves F were involved in data curation and formal analysis in this study; Pinheiro MG, Alves GGO, Conde MER, Costa SL, Sant’Anna RCS, Antunes IMF, Carneiro MC, Ronzei FS, Scaffo JC, Pinheiro FR, Andre LS, Povoa HC, Baltar VT, Giordani F, Hemerly ES, Alexandre GC, de Paula KC, Watanabe M, Nóbrega ACLD, Lobato JCP, and Aguiar-Alves F were involved developing the methodology, writing, validation, investigation and visualization of the study; all of the authors read and approved the final version of the manuscript to be published.
Supported by The Fluminense Federal University.
Institutional review board statement: The study protocol received approval from the Appropriate Ethics Committee of the Medicine University–Fluminense Federal University. Prior to participating, all individuals provided informed consent. Throughout the study, patient information was handled with strict confidentiality and privacy.
Informed consent statement: Informed written consent was obtained from all participants before they were enrolled in the study.
Conflict-of-interest statement: The authors have no conflicts of interest to disclose.
Data sharing statement: Consent was obtained from all participants prior to their inclusion in the study. Patient information was handled with strict confidentiality and privacy throughout the entire process. The data are not publicly available due to privacy or ethical restrictions.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Fabio Aguiar-Alves, DSc, MSc, PharmD, Associate Professor, Depart ment of Pharmaceutical Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, 901 S Flagler Drive, West Palm Beach, FL 33401, United States. fabio_aguiaralves@pba.edu
Received: August 20, 2024
Revised: September 30, 2024
Accepted: November 1, 2024
Published online: March 25, 2025
Processing time: 99 Days and 6 Hours
Revised: September 30, 2024
Accepted: November 1, 2024
Published online: March 25, 2025
Processing time: 99 Days and 6 Hours
Core Tip
Core Tip: This study highlights the significance of serological surveillance in a university population during the coronavirus disease 2019 (COVID-19) pandemic. The findings show that age, contact with COVID-19-positive individuals, and vaccination status are positively associated with the manifestation of severe acute respiratory syndrome-coronavirus 2 antibodies. Additionally, adherence to social distancing measures significantly reduces the likelihood of infection. The prevalence of infection increased with relaxed social distancing practices, emphasizing the continued importance of preventive measures in controlling viral transmission.